133.96
133.96 (0%)
As of Feb 14, 2025
Jazz Pharmaceuticals Plc [JAZZ]
Source:
Company Overview
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options.
| Country | United States |
| Headquarters | dublin |
| Phone Number | 353-1-634-7800 |
| Industry | manufacturing |
| CEO | Bruce C. Cozadd |
| Website | www.jazzpharmaceuticals.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,069 |
| Operating Profit | $716.6 |
| Net Income | $560.1 |
| Net Cash | $906.6 |
Profit Ratios
| Gross Margin | $3,623.2 |
| Operating Margin | 17.6 |
| Profit as % of Revenues | 646.9% |
| Profit as % of Assets | 4.8% |
| Profit as % of Stockholder Equity | 13.7% |
Management Effectiveness
| Return on Equity | 13.7% |
| Return on Assets | 4.7% |
| Turnover Ratio | 34.8% |
| EBITA | $1,343.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $12,012.3 |
| Total Liabilities | $7,918.5 |
| Operating Cash Flow | $1,395.9 |
| Investing Cash Flow | $-508.2 |
| Financing Cash Flow | $20.5 |
